319 related articles for article (PubMed ID: 17893577)
1. Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits.
Wang M; Etu J; Joshi S
J Neurosurg Anesthesiol; 2007 Oct; 19(4):249-56. PubMed ID: 17893577
[TBL] [Abstract][Full Text] [Related]
2. The effects of pentobarbital on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Chun TW; Liu X; Weiss HR
Anesth Analg; 1998 Jun; 86(6):1230-5. PubMed ID: 9620510
[TBL] [Abstract][Full Text] [Related]
3. Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy.
Joshi S; Ergin A; Wang M; Reif R; Zhang J; Bruce JN; Bigio IJ
J Neurooncol; 2011 Aug; 104(1):11-9. PubMed ID: 21153681
[TBL] [Abstract][Full Text] [Related]
4. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Kaya M; Gulturk S; Elmas I; Kalayci R; Arican N; Kocyildiz ZC; Kucuk M; Yorulmaz H; Sivas A
Life Sci; 2004 Nov; 76(2):201-12. PubMed ID: 15519365
[TBL] [Abstract][Full Text] [Related]
5. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate.
Preston E; Slinn J; Vinokourov I; Stanimirovic D
J Neurosci Methods; 2008 Mar; 168(2):443-9. PubMed ID: 18155299
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyethyl starch solution attenuates blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Lu X; Wei HM; Williams JA; Weiss HR
Anesth Analg; 1996 Aug; 83(2):336-41. PubMed ID: 8694315
[TBL] [Abstract][Full Text] [Related]
7. Transient cerebral hypoperfusion enhances intraarterial carmustine deposition into brain tissue.
Joshi S; Wang M; Etu JJ; Suckow RF; Cooper TB; Feinmark SJ; Bruce JN; Fine RL
J Neurooncol; 2008 Jan; 86(2):123-32. PubMed ID: 17634743
[TBL] [Abstract][Full Text] [Related]
8. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain.
Erdlenbruch B; Schinkhof C; Kugler W; Heinemann DE; Herms J; Eibl H; Lakomek M
Br J Pharmacol; 2003 Jun; 139(4):685-94. PubMed ID: 12812991
[TBL] [Abstract][Full Text] [Related]
9. Intra-arterial delivery of AAV vectors to the mouse brain after mannitol mediated blood brain barrier disruption.
Foley CP; Rubin DG; Santillan A; Sondhi D; Dyke JP; Crystal RG; Gobin YP; Ballon DJ
J Control Release; 2014 Dec; 196():71-78. PubMed ID: 25270115
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
11. Effects of intracarotid hyperosmolar mannitol in triethyl tin (TET)-induced rat brain edema--preservation of blood-brain barrier (BBB) in TET edema.
Inoue T; Nagara H; Kondo A; Fukui M; Tateishi J
Brain Res; 1987 Jun; 414(2):309-13. PubMed ID: 3113663
[TBL] [Abstract][Full Text] [Related]
12. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption.
Yang W; Barth RF; Carpenter DE; Moeschberger ML; Goodman JH
Neurosurgery; 1996 May; 38(5):985-92. PubMed ID: 8727825
[TBL] [Abstract][Full Text] [Related]
13. Comparison of various methods for delivering radiolabeled monoclonal antibody to normal rat brain.
Bullard DE; Bourdon M; Bigner DD
J Neurosurg; 1984 Nov; 61(5):901-11. PubMed ID: 6436447
[TBL] [Abstract][Full Text] [Related]
14. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR
Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
[TBL] [Abstract][Full Text] [Related]
15. Cerebral blood flow affects dose requirements of intracarotid propofol for electrocerebral silence.
Joshi S; Wang M; Etu JJ; Nishanian EV; Pile-Spellman J
Anesthesiology; 2006 Feb; 104(2):290-8, discussion 5A. PubMed ID: 16436848
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Hyperosmotic and Immune-Induced Disruption of the Blood-Brain Barrier by the Nitric Oxide System.
Hasarmeh M; Itzik A; Weidenfeld J; Ovadia H
Neuroimmunomodulation; 2016; 23(1):1-7. PubMed ID: 26670748
[TBL] [Abstract][Full Text] [Related]
17. Real-time hemodynamic response and mitochondrial function changes with intracarotid mannitol injection.
Joshi S; Singh-Moon R; Wang M; Bruce JN; Bigio IJ; Mayevsky A
Brain Res; 2014 Feb; 1549():42-51. PubMed ID: 24440631
[TBL] [Abstract][Full Text] [Related]
18. Polyamines mediate the reversible opening of the blood-brain barrier by the intracarotid infusion of hyperosmolal mannitol.
Koenig H; Goldstone AD; Lu CY
Brain Res; 1989 Mar; 483(1):110-6. PubMed ID: 2495841
[TBL] [Abstract][Full Text] [Related]
19. Effects of suxamethonium on the cerebrum following disruption of the blood-brain barrier in dogs.
Lanier WL; Milde JH; Sharbrough FW
Br J Anaesth; 1990 Nov; 65(5):708-12. PubMed ID: 2123396
[TBL] [Abstract][Full Text] [Related]
20. Optically measured NADH concentrations are unaffected by propofol induced EEG silence during transient cerebral hypoperfusion in anesthetized rabbits.
Wang M; Agarwal S; Mayevsky A; Joshi S
Brain Res; 2011 Jun; 1396():69-76. PubMed ID: 21570061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
